Simplex Trading
OMED

Simplex Trading’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Simplex Trading’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-15
Closed – – 8446
2018
Q4 		$0 Sell
15
-3,933
-100% -$5.92K ﹤0.01% 8549
2018
Q3 		$8K Sell
3,948
-16,354
-81% -$39.2K ﹤0.01% 6586
2018
Q2 		$46K Buy
20,302
+7,243
+55% +$21.1K ﹤0.01% 5163
2018
Q1 		$41K Buy
+13,059
New +$36K ﹤0.01% 2644
2017
Q4 		– Sell
-3,444
Closed -$15K – 7355
2017
Q3 		$15K Sell
3,444
-3,590
-51% -$14.5K ﹤0.01% 3456
2017
Q2 		$23K Sell
7,034
-30,402
-81% -$126K ﹤0.01% 3192
2017
Q1 		$344K Buy
37,436
+20,151
+117% +$177K 0.01% 894
2016
Q4 		$133K Sell
17,285
-7,392
-30% -$67.9K 0.01% 1323
2016
Q3 		$282K Buy
24,677
+21,489
+674% +$250K 0.02% 814
2016
Q2 		$39K Buy
3,188
+1,297
+69% +$15.7K ﹤0.01% 2303
2016
Q1 		$19K Sell
1,891
-8,128
-81% -$95.4K ﹤0.01% 2884
2015
Q4 		$225K Buy
10,019
+5,336
+114% +$109K 0.02% 811
2015
Q3 		$77K Sell
4,683
-1,448
-24% -$29K 0.01% 1641
2015
Q2 		$137K Buy
+6,131
New +$151K 0.01% 1016

Other funds holding OMED

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Simplex Trading's OMED Position: Q1 2019 in Review

Simplex Trading sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q1 2019, closing a stake of 15 shares.

Simplex Trading first reported a position in OMED in Q2 2015 and held it in 14 quarters. The position peaked at $344K in Q1 2017. 41 funds tracked by Wall St. Rank hold OMED as of Q1 2019.

  • Simplex Trading reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Simplex Trading sold 15 OncoMed Pharmaceuticals, Inc. shares in Q1 2019.
  • Simplex Trading first reported a position in OncoMed Pharmaceuticals, Inc. in Q2 2015 and held it in 14 quarters.
  • Simplex Trading's OncoMed Pharmaceuticals, Inc. position peaked at $344K in Q1 2017.
  • 41 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q1 2019.

Based on Simplex Trading's 13F filing for Q1 2019, filed 18 Apr 2019.